Publications by authors named "C Borel"

Claim this Profile
N
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.
Jean Bourhis, Anne Aupérin, Christian Borel, Gautier Lefebvre, Severine Racadot

Lancet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.
D M Filippini, B Cabarrou, C Dupain, M Halladjian, E Coquan, C Borel

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid/lymphoid neoplasm with PCM1::JAK2 rearrangement presenting as secondary Burkitt lymphoma.
Carla Sixou, Alban Canali, Cécile Borel, Jean-Baptiste Rieu

Ann Biol Clin (Paris)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining a need for rapid response and practical guidance for recurrent and metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) management in France: A Delphi consensus.
Florian Clatot, Caroline Even, Amaury Daste, Christian Borel, Jérôme Fayette

PLoS One· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.
Edith Borcoman, Bastien Cabarrou, Miguel Francisco, Frédéric Bigot, François Ghiringhelli, Christian Borel

Nat Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis